These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 5829925)
1. [Observations on the 17 D virus vaccine against yellow fever, applied by cutaneous scarification]. Groot H; Gast-Galvis A Rev Invest (Guadalajara); 1965 Apr; 5(1):5-25. PubMed ID: 5829925 [No Abstract] [Full Text] [Related]
3. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? Barrett AD; Teuwen DE Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559 [TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program. Collaborative Group for Studies with Yellow Fever Vaccine Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925 [TBL] [Abstract][Full Text] [Related]
5. Lymphocytes and yellow fever. I. Transient virus refractory state following vaccination of man with the 17-D strain. Wheelock EF; Toy ST; Stjernholm RL J Immunol; 1970 Nov; 105(5):1304-6. PubMed ID: 5496134 [No Abstract] [Full Text] [Related]
6. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination. Adu FD; Adeniji JA; Tomori O; Adelasoye A Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476 [TBL] [Abstract][Full Text] [Related]
9. [Simultaneous vaccination against hepatitis A and yellow fever]. Receveur MC; Quiniou JM; Delprat P; Monlun E; Lehner V; Le Bras M Bull Soc Pathol Exot; 1993; 86(5 Pt 2):406-9. PubMed ID: 7819790 [TBL] [Abstract][Full Text] [Related]
10. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination. Adu FD; Adeniji JA; Tomori O; Adelasoye A Rom J Virol; 1993; 44(1-2):3-7. PubMed ID: 9702244 [TBL] [Abstract][Full Text] [Related]
11. [Anti-yellow fever vaccination]. Finelli L Acta Med Ital Med Trop Subtrop Gastroenterol; 1963 Oct; 18(10):303-11. PubMed ID: 5173845 [No Abstract] [Full Text] [Related]
12. Quantitation of protein content by biuret method during production of Yellow Fever Vaccine. Shrivastaw KP; Singh S; Sharma SB; Sokhey J Biologicals; 1995 Dec; 23(4):299-300. PubMed ID: 8825858 [TBL] [Abstract][Full Text] [Related]
13. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005. Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927 [TBL] [Abstract][Full Text] [Related]
15. Yellow fever vaccines, a consideration of different types and their field trials. MACNAMARA FN West Afr Med J; 1955 Sep; 4(3):124-9. PubMed ID: 13274776 [No Abstract] [Full Text] [Related]
16. Yellow fever vaccination in the Americas. Bull Pan Am Health Organ; 1984; 18(2):188-92. PubMed ID: 6207882 [TBL] [Abstract][Full Text] [Related]
17. [Yellow fever antibodies in gamma globulin preparations after vaccination. Determination using simple neutralization tests on cultured cells]. Huber HC; Hochstein-Mintzel V; Ritter U Offentl Gesundheitswes; 1981 Apr; 43(4):191-4. PubMed ID: 6164969 [No Abstract] [Full Text] [Related]
18. Yellow fever-associated viscerotropic disease in Barcelona, Spain. Muñoz J; Vilella A; Domingo C; Nicolas JM; de Ory F; Corachan M; Tenorio A; Gascon J J Travel Med; 2008; 15(3):202-5. PubMed ID: 18494699 [TBL] [Abstract][Full Text] [Related]
19. Heterotypic serologic responses after yellow fever vaccination; detection of persons with past St. Louis encephalitis or dengue. Pond WL; Ehrenkranz NJ; Danauskas JX; Carter MJ J Immunol; 1967 Apr; 98(4):673-82. PubMed ID: 6022887 [No Abstract] [Full Text] [Related]